You are requesting information on: Developing A Novel Lipid Nanoparticle (LNP) Platform Enabling Effective Passive And Active Immune Cell Targeting Strategies For In Vivo CAR T Cell Therapy Cytiva
Already a member of Advancing RNA or VertMarkets? Sign in now.
In order for our suppliers to better serve your request, please enter specific requirements or questions below: